Orchid Pharma Ltd Half Yearly Results

Gross Sales

454.82

467.1

437.69

381.68

369.66

Excise Duty

0

0

0

0

0

Net Sales

454.82

467.1

437.69

381.68

369.66

Other Operating Income

0

0

0

0

0

Other Income

12.39

15.09

20.62

10.24

49.87

Total Income

467.21

482.19

458.31

391.92

419.53

Total Expenditure

400.48

404.27

372.48

336.22

323.09

PBIDT

66.73

77.92

85.84

55.7

96.44

Interest

7.71

6.83

7

9.35

15.16

PBDT

59.02

71.09

78.84

46.35

81.28

Depreciation

17.48

17.07

17.69

15.55

15.39

Minority Interest Before NP

0

0

0

0

0

Tax

0.06

-0.15

0.11

0

0

Deferred Tax

-0.1

0

-3.23

0

0

Reported Profit After Tax

41.58

54.17

64.27

30.8

65.88

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

43.07

56.59

62.96

29.21

66.73

Extra-ordinary Items

0

0

0

0

32.44

Adjusted Profit After Extra-ordinary item

43.07

56.59

62.96

29.21

34.29

EPS (Unit Curr.)

8.49

11.16

12.41

6.35

16.35

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

50.72

50.72

50.72

50.72

40.82

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

14.67

16.68

19.61

14.59

26.08

PBDTM(%)

-

-

-

-

-

PATM(%)

9.14

11.59

14.68

8.06

17.82